{ "items": [ "\n\n
\n \n 21 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nA ground-breaking experimental medicine programme that will enable researchers to more rapidly screen potential drugs in people with motor neuron disease (MND, also known as ALS), is announced today on Global MND Awareness Day.
\n \n\n\n \n 15 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 12 June 2023\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nBeacon Therapeutics, a pioneering new biotech company, has launched with a mission to restore and improve the vision of patients with retinal diseases. The company is one of the most ambitious spinouts the University has been involved in to date, starting out with an impressive \u00a396 million ($118.5m) in funding, the biggest launch for any company including an Oxford spin-out programme.
\n \n\n\n \n 26 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford and Selvita (WSE: SLV), one of the largest contract research organisations in Europe, are collaborating on drug discovery in the area of Parkinson's disease
\n \n\n\n \n 18 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Espie is one of eight Oxford researchers to become Fellows of the Academy of Medical Sciences.
\n \n\n\n \n 2 May 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nTwo papers by early career researchers in our Oxford Epilepsy Research Group have been highlighted recently.
\n \n\n\n \n 26 April 2023\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n \n \n Stroke & Dementia\n \n \n\n \n\n\n
\n \n\n \n \n \nA new study has shown the need for more widespread screening for frailty in unplanned admissions to hospitals to better inform the care received by patients.
\n \n\n\n \n 20 April 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nAnd the certainty of evidence supporting its use is low, say researchers
\n \n\n\n \n 14 March 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe
\n \n\n\n \n 9 March 2023\n \n
\n\n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe British Neuroscience Association Scholars Programme was launched in 2021 with a view to improving equality, diversity and inclusion in neuroscience.
\n \n\n\n \n 7 March 2023\n \n
\n\n \n\n \n\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe MRC Brain Network Dynamics Unit has received funding for a multi-year research partnership designed to advance the understanding of early changes to the operations of brain circuits in Alzheimer's disease.
\n \n\n\n \n 6 March 2023\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nOn 21 February, Robert MacLaren organised a one-day ophthalmology conference in Kyiv together with Dr Andrii Ruban, President of the Ukrainian Vitreoretinal Society.
\n \n\n\n \n 31 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nThe first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.
\n \n\n\n \n 3 January 2023\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNMDAR-antibody encephalitis is an autoimmune brain condition caused by patient\u2019s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.
\n \n\n\n \n 15 December 2022\n \n
\n\n \n\n \n\n \n \n \n \n MRC BNDU\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nFrom 2 January 2023, Professor Peter Magill will lead the Medical Research Council Brain Network Dynamics Unit (MRC BNDU) at the University of Oxford.
\n \n\n\n \n 21 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n\n \n 14 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Coronavirus\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nNew research from the University of Oxford has shown an increased risk of severe illness and death from both COVID-19 and other severe respiratory infections, such as influenza and pneumonia, among people with a pre-existing mental health condition.
\n \n\n\n \n 10 November 2022\n \n
\n\n \n\n \n\n \n \n \n \n Clinical Neurology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nEstablishing preclinical models of Alzheimer\u2019s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer\u2019s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.
\n \n\n\n \n 19 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Ophthalmology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \nEarlier this month, we were delighted to welcome the Director of the Sir Jules Thorn Charitable Trust, Richard Benson, and its Chair of Trustees, Liz Charal.
\n \n\n\n \n 17 October 2022\n \n
\n\n \n\n \n\n \n \n \n \n Anaesthetics\n \n \n \n \n Award\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n \n \n \n \n\n